Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 50032026
TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416448(CHEMBL1209159)
Affinity DataKi:  0.398nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416445(CHEMBL1209162)
Affinity DataKi:  0.631nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416460(CHEMBL1209345)
Affinity DataKi:  0.631nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416443(CHEMBL1209216)
Affinity DataKi:  0.794nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416447(CHEMBL1209160)
Affinity DataKi:  0.794nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416454(CHEMBL1209052)
Affinity DataKi:  1nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416450(CHEMBL1209101)
Affinity DataKi:  1nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416449(CHEMBL1209102)
Affinity DataKi:  1nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416436(CHEMBL1209346)
Affinity DataKi:  1.26nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416453(CHEMBL1209053)
Affinity DataKi:  1.58nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416438(CHEMBL1209280)
Affinity DataKi:  1.58nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416457(CHEMBL1209049)
Affinity DataKi:  2.51nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416455(CHEMBL1209051)
Affinity DataKi:  2.51nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416437(CHEMBL1209281)
Affinity DataKi:  3.98nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416439(CHEMBL1209279)
Affinity DataKi:  3.98nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416442(CHEMBL1209218)
Affinity DataKi:  5.01nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416444(CHEMBL1209215)
Affinity DataKi:  5.01nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416452(CHEMBL1209100)
Affinity DataKi:  5.01nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416446(CHEMBL1209161)
Affinity DataKi:  6.31nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50323463(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)
Affinity DataKi:  7.94nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416456(CHEMBL1209050)
Affinity DataKi:  12.6nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416459(CHEMBL1209347)
Affinity DataKi:  15.8nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416441(CHEMBL1209277)
Affinity DataKi:  31.6nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416451(CHEMBL1208795)
Affinity DataKi:  50.1nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416440(CHEMBL1209278)
Affinity DataKi:  1.00E+3nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 5(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416458(CHEMBL1208996)
Affinity DataKi:  2.51E+3nMAssay Description:Antagonist activity at human NPY Y5 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416459(CHEMBL1209347)
Affinity DataKi: >3.16E+4nMAssay Description:Antagonist activity at human NPY Y1 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetNeuropeptide Y receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50416459(CHEMBL1209347)
Affinity DataKi: >3.16E+4nMAssay Description:Antagonist activity at human NPY Y2 receptor expressed in HEK293 cells assessed as inhibition of calcium level by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetPotassium voltage-gated channel subfamily H member 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50323463(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50323463(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCytochrome P450 1A2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50323463(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCytochrome P450 2C19(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50323463(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCytochrome P450 3A4(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50323463(CHEMBL1209217 | endo-(6-((4-(pyridin-2-yl)thiazol-...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed